Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Notes Payables (2013 - 2020)

Updated

Dare Bioscience's Notes Payables came in at $367,285 for Q4 2020, unchanged from the prior quarter.

Analysis

Dare Bioscience (DARE) Notes Payables (2013 - 2020) Analysis & Trends

Going back to Q4 2013, Dare Bioscience's Notes Payables data covers 6 quarters.

  • Notes Payables carries a four-year compound annual growth rate of -14.8% (FY2016 to FY2020).
  • Going back by year, Notes Payables was $697,500 in FY2016.
  • The five-year range for quarterly Notes Payables is $367,285 (Q2 2020) to $697,500 (Q4 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 367,285.00
Sep 30, 2020 367,285.00
Jun 30, 2020 367,285.00
Dec 31, 2016 697,500.00
Mar 31, 2014 17.32 Mn
Dec 31, 2013 8.82 Mn
API Access

Dare Bioscience Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=DARE&period=max&api_key=YOUR_API_KEY